Table 1.

Gender and age mean of patients and healthy subjects.

	Gender (Male/Female)	Age – mean (Male/Female)
Healthy subjects	5/5	41.1/42.8
Patients without therapy	6/2	44.6/56.5
Patients treated with methotrexate	7/7	52.8/46.6
Patients treated with adalimumab	5/5	43.2/46.1